论文-万方医学网

1. Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs

【外文期刊】 Kawashiri, Shin-Ya ; Nishino, Ayako ; 等《Modern rheumatology》 2017年27卷2期 252-256页 SCIEMEDLINE

【关键词】 Biologic disease-modifying anti-rheumatic drugs (bDMARDs); Gray scale; Power Doppler;

原文传递

浏览：0 被引：0 下载：0

2. Frequency of severe infections in rheumatic disease patients receiving bDMARDs post-kidney transplantation: a multicenter study.

【外文期刊】 Tuba Demirci,Yıldırım ; Emel Oğuz,Kökoğlu ; 等《Clinical rheumatology》 SCIMEDLINE

【关键词】 Biologic disease-modifying anti-rheumatic drugs (bDMARDs); Kidney transplantation; Rheumatic diseases;

LinkOut

浏览：0 被引：0 下载：0

3. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.

【外文期刊】 Aislinn F,Lalor ; Joanne E,Brooker ; 等《Seminars in arthritis and rheumatism》 2022年55卷 151988页 SCIMEDLINEBP

【关键词】 Axial SpA, Axial spondyloarthritis; Biologic therapies; DMARDs, Disease-modifying anti-rheumatic drugs;

LinkOut

浏览：2 被引：0 下载：0

4. Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.

【外文期刊】 Shin-Ya,Kawashiri ; Ayako,Nishino ; 等《Modern rheumatology》 2017年27卷2期 252-256页 SCIMEDLINE

【关键词】 Biologic disease-modifying anti-rheumatic drugs (bDMARDs); Gray scale; Power Doppler;

LinkOut

浏览：42 被引：0 下载：0

5. Dose Tapering and Discontinuation of Biologic DMARDs in Axial Spondyloarthritis: A Narrative Review (2023 SPARTAN Annual Meeting Proceedings).

【外文期刊】 Haseeb,Chaudhary ; Mohamad,Bittar ; 等《Current rheumatology reports》 2024年26卷5期 155-163页 SCIMEDLINE

【关键词】 Axial spondyloarthritis; Biologic disease modifying anti-rheumatic drugs; TNFi;

OA

浏览：0 被引：0 下载：0

6. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy.

【外文期刊】 Wenhui,Wei ; Keith,Knapp ; 等《Advances in therapy》 2017年34卷8期 1936-1952页 SCIMEDLINEBP

【关键词】 Biologic disease-modifying anti-rheumatic drugs; Persistence; Rheumatoid arthritis;

OA

浏览：97 被引：0 下载：0

7. Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy

【外文期刊】 Wenhui Wei ; Keith Knapp ; 等《Advances in therapy.》 2017年34卷8期 1936-1952页 SCISCIEMEDLINE

【关键词】 Biologic disease-modifying anti-rheumatic drugs; bDMARDs; Persistence;

原文传递

浏览：0 被引：0 下载：0

8. Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis

【外文期刊】 Kihara, Mari ; Davies, Rebecca ; 等《Clinical rheumatology》 2017年36卷2期 241-250页 SCISCIEMEDLINE

【关键词】 Biological disease modifying anti-rheumatic drugs (bDMARDs); Observational study; Rheumatoid arthritis;

原文传递

浏览：2 被引：0 下载：0

9. Nutritional status as the risk factor of serious infection in patients with rheumatoid arthritis

【外文期刊】 Hasegawa, Eriko ; Kobayashi, Daisuke ; 等 2020年30卷6期 982-989页 SCIEMEDLINE

【关键词】 Biological disease-modifying anti-rheumatic drugs (bDMARDs); infection; glucocorticoid;

原文传递

浏览：0 被引：0 下载：0

检索历史清除

模糊

与

模糊

与

模糊

开始

结束

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

模糊

与

模糊

与

模糊

开始

结束

批量导出

批量导出

检索历史清除